Top Five: Quality Systems, Treehouse Foods

TheStreet.com Ratings provides exclusive stock, ETF and mutual fund recommendations using proprietary tools. Our "safety first" approach aims to reduce risk while achieving total return performance.

BOSTON (TheStreet) -- The following companies are projected to increase revenue and profit by at least 12% in the coming year. They receive "buy" ratings from our proprietary quantitative model, which considers more than 60 factors. They are ordered by their potential to appreciate.

Strayer Education(STRA Quote) is a for-profit post-secondary education company that offers a variety of academic programs through Strayer University.

The numbers: Second-quarter revenue increased 29% to $126 million as net income climbed 29% to $28 million and earnings per share jumped 33% to $2. The operating margin climbed from 34% to 36% and the net margin remained steady at 22%. Strayer has no debt or interest expenses. And a quick ratio of 1.6 indicates ample liquidity.

The stock: Strayer is up 1% in 2009, underperforming the Dow Jones Industrial Average and S&P 500 Index. The stock trades at an expensive price-to-earnings ratio of 35 and offers a dividend yield below 1%.

Teva Pharmaceuticals(TEVA Quote) is an Israeli company that develops and markets a range of generic and branded pharmaceuticals, biogenerics and active pharmaceutical ingredients.

The numbers: Second-quarter revenue ascended 20% to $3.4 billion as net income dropped 2% to $521 million and earnings per share fell 11% to 58 cents, hurt by a higher share count. The operating margin improved from 23% to 24% and the net margin dropped from 19% to 15%. A quick ratio of 0.9 indicates a less-than-ideal liquidity position. And a debt-to-equity ratio of 0.4 reflects a modest debt load.

The stock: Teva is up 24% in 2009, beating the Dow and S&P 500. The stock trades at a price-to-earnings ratio of 55, indicating a significant premium to the market, and offers a modest 1.2% dividend yield.